Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9950
+0.0150 (1.53%)
At close: Oct 30, 2026, 4:00 PM EDT
1.010
+0.015 (1.51%)
After-hours: Oct 30, 2026, 4:58 PM EDT
Cocrystal Pharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Cocrystal Pharma stock has a consensus rating of "Strong Buy" and an average price target of $8.00. The average 1-year stock price forecast is 704.02% higher than the current stock price, while the lowest is $6.00 (+503.02%) and the highest is $10 (+905.03%).
Price Target: $8.00 (+704.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cocrystal Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +503.02% | Oct 9, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $10 | Buy | Reiterates | $10 | +905.03% | May 27, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.73
from -0.78
EPS Next Year
-0.48
from -0.73
EPS and Forward PE are based on non-GAAP adjusted numbers.